Compounds > ym 16638
Page last updated: 2024-09-03

ym 16638 and Asthma, Bronchial

ym 16638 has been researched along with Asthma, Bronchial in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tohda, Y1
Hara, H; Mase, T; Murase, K; Tomioka, K; Yamada, T1

Reviews

1 review(s) available for ym 16638 and Asthma, Bronchial

ArticleYear
[My research on asthma today and in the future].
    Arerugi = [Allergy], 2013, Volume: 62, Issue:11

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Asthma; Bronchial Hyperreactivity; Disease Models, Animal; Humans; Interleukin-4; Labetalol; Lymphocytes; Phosphoric Diester Hydrolases; Propranolol; Receptors, GABA; Receptors, Muscarinic; Theophylline; Thiadiazoles

2013

Other Studies

1 other study(ies) available for ym 16638 and Asthma, Bronchial

ArticleYear
Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:5

    Topics: Animals; Asthma; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Lung; Muscle Contraction; Muscle, Smooth; Skin Tests; SRS-A; Thiadiazoles; Trachea

1988